Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
275 studies found for:    Cerebral Atrophy
Show Display Options
Rank Status Study
21 Recruiting Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients
Conditions: Alzheimer's Disease;   Hypertension
Interventions: Drug: Perindopril;   Drug: Telmisartan
22 Withdrawn A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: testosterone;   Drug: placebo gel
23 Completed Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Conditions: Multiple Sclerosis;   Fatigue
Interventions: Drug: 3,4-diaminopyridine;   Drug: Placebo
24 Completed PET Imaging in Chronic Traumatic Encephalopathy
Conditions: Brain Disease;   Brain Mapping
Intervention:
25 Recruiting Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
Conditions: Primary Progressive Multiple Sclerosis;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: Andrographolides;   Drug: placebo
26 Completed Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
27 Active, not recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
28 Active, not recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
29 Completed Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Interventions: Drug: natalizumab;   Other: standard of care
30 Active, not recruiting Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Biological: natalizumab
31 Not yet recruiting MRI Markers of Outcome After Severe Pediatric TBI
Condition: Brain Injuries
Intervention: Other: MRI Scans
32 Completed Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Conditions: Atypical Alzheimers Disease;   Logopenic Variant of Primary Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
Intervention: Drug: C-11 PiB
33 Not yet recruiting Automated Brain Morphometry for Dementia Diagnosis
Condition: Dementia
Interventions: Device: Brain Morphometry;   Other: Standard radiological assessment
34 Completed Clinical Findings in General Paresis
Condition: General Paresis
Intervention:
35 Recruiting Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction
Conditions: Postoperative Cognitive Dysfunction;   Delirium;   Dementia
Intervention:
36 Not yet recruiting Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression
Condition: Major Depressive Disorder
Intervention: Behavioral: Problem Solving Therapy
37 Terminated Flupirtine as Oral Treatment in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Flupirtine;   Drug: Placebo
38 Active, not recruiting Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
Condition: Multiple System Atrophy
Interventions: Drug: EGCG as putative neuroprotective agent;   Drug: Placebo
39 Recruiting DANish DELIrium Study On Neurointensive Care Patients
Conditions: Acquired Brain Injuries;   Delirium;   Acute Brain Injury
Intervention: Other: intervention bundle (sedation, pain, mobilization and sleep)
40 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years